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ABSTRACT
Background and purpose of the study: Herbal enhancers compared to the synthetic ones have 
shown less toxis effects. Coumarins have been shown at concentrations inhibiting phospoliphase 
C-Y (Phc-Y) are able to enhance tight junction (TJ) permeability due to hyperpoalation of 
Zonolous Occludense-1 (ZO-1) proteins. The purpose of this study was to evaluate the influence 
of ethanolic extract of Angelica archengelica (AA-E) which contain coumarin on permeation of 
repaglinide across rat epidermis and on the tight junction plaque protein ZO-1 in HaCaT cells.
Methods: Transepidermal water loss (TEWL) from the rat skin treated with different 
concentrations of AA-E was assessed by Tewameter. Scanning and Transmission Electron 
Microscopy (TEM) on were performed on AA-E treated rat skin portions. The possibility of 
AA-E influence on the architecture of tight junctions by adverse effect on the cytoplasmic  
ZO-1 in HaCaT cells was investigated. Finally, the systemic delivery of repaglinide from the 
optimized transdermal formulation was investigated in rats.
Results: The permeation of repaglinide across excised rat epidermis was 7-fold higher in the 
presence of AA-E (5% w/v) as compared to propylene glycol:ethanol (7:3) mixture. The extract 
was found to perturb the lipid microconstituents in both excised and viable rat skin, although, 
the effect was less intense in the later. The enhanced permeation of repaglinide across rat 
epidermis excised after treatment with AA-E (5% w/v) for different periods was in concordance 
with the high TEWL values of similarly treated viable rat skin. Further, the observed increase 
in intercellular space, disordering of lipid structure and corneocyte detachment indicated 
considerable effect on the ultrastructure of rat epidermis. Treatment of HaCaT cell line with 
AA-E (0.16% w/v) for 6 hrs influenced ZO-1 as evidenced by reduced immunofluorescence of 
anti-TJP1 (ZO-1) antibody in Confocal Laser Scanning Microscopy studies (CLSM) studies. 
The plasma concentration of repaglinide from transdermal formulation was maintained higher 
and for longer time as compared to oral administration of repaglinide.
Major conclusion: Results suggest the overwhelming influence of Angelica archengelica in 
enhancing the percutaneous permeation of repaglinide to be mediated through perturbation of 
skin lipids and tight junction protein (ZO-1).
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INTRODUCTION
One of the approaches towards broadening the 
array of drugs that can be successfully delivered 
transdermally is the use of permeation enhancers. 
However, the synthetic enhancers (surfactants) that 
are commonly used in transdermal formulations are 
reported to be transported across the skin and may 
exert toxic effect on prolonged uses. Reversibility 
of the skin perturbation is of prime importance in 
selecting a permeation enhancer and as a result, there 
is renewed interest for searching safe and effective 
permeation enhancers.
Permeation enhancers can act on intercellular lipid 
domains of the stratum corneum, intercellular 
keratin, and tight junctional proteins or alter the 
solvent characteristics of the stratum corneum in 
order to decrease the barrier resistance of skin (1). 
The tight junction (TJ) proteins are known to exist 
in a variety of cells and have been recently reported 
to be present in the epidermis where they exist in the 
apical portion of the cells of the stratum granulosum 
and provide a barrier to both inward and outward 
movement of molecules (2, 3). The TJ proteins 
play an important role in cell signaling (4, 5) and 
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vesicular transport (6). ZO-1 and F- actin have been 
recognized to be the key elements in the structural 
organization of TJ complexes (7). Recent reports 
suggest that disruption of the organization of TJ 
components, especially ZO-1 and F- actin, can affect 
the barrier integrity and hence, offer a novel means 
for enhancement of the percutaneous delivery of 
drug molecules.
Roots of Angelica archangelica contain essential 
oils, organic acids, steroids, coumarins and 
flavonoids and have been used for strengthening of 
the heart, stimulating the circulation and immune 
system. Ethanolic extract of the roots of Angelica 
archangelica (AA-E) has been reported to contain 
high concentration of coumarins (8). The in vitro 
percutaneous absorption and skin metabolism of 
coumarin (1,2-benzopyrone) has been studied in 
metabolically viable human, rat (F344), and mouse 
(CD1 and DBA/2) skin. 3-Nitrocomarin (3-NC), at 
concentrations inhibiting phospholipase C-у (PLC- 
у)  is  able  to  enhance TJ  permeability  (1)  due  to 
hyperphosphorylation of ZO-1 protein. There is no 
report relating to the use of AA-E for enhancement 
of the permeation of drugs across skin. Therefore, 
it seemed rational to hypothesize the influence of 
AA-E on the barrier status of skin though its action 
on ZO-1 protein. Hence, the inclusion of AA-E in 
transdermal formulations may be anticipated to 
offer a means for enhancement of the percutaneous 
permeation of drugs.
This investigation was designed to evaluate the 
effect of AA-E on the barrier status of rat epidermis. 
Biochemical constituents, transepidermal water 
loss (TEWL) and ultrasturactural features were 
investigated as markers of the barrier integrity of 
rat epidermis. In addition, the effect of AA-E on 
tight junction protein (ZO-1) was evaluated in 
human normal skin keratinocyte cell line (HaCaT). 
Constant concentration of repaglinide (RGE) an oral 
antidiabetic drug is required to be maintained in blood 
for effective control of blood glucose level due to its 
extremely short half-life of one hour (9). Hence, the 
possibility of using AA-E for enhancement of the 
permeation of RGE was evaluated through in vitro 
diffusion studies. Finally, exploratory studies were 
conducted to assess the systemic delivery of RGE in 
rats from transdermal formulations containing AA-E 
as permeation enhancer. 
MATERIAL AND METHODS
RGE was obtained from Torrent Pharmaceuticals, 
(India) as a gift sample. Skin for the in vitro 
permeation and other studies was obtained from 
albino Wistar rats (190-210g) of either sex. The 
protocols for these studies were approved by the 
Institutional Animal Ethics Committee of Punjabi 
University, Patiala, India. All chemicals used in this 
study were of AR grade.
Extraction and standardization of Angelica 
archangelica
The powdered dried roots of Angelica archangelica 
were extracted using the method described by 
Ganzera (8). 
Preparation of epidermal sheet for in vitro 
permeation studies
Full thickness skin samples were obtained from 
Albino Wistar rats of either sex (175–225  g). 
Epidermal sheets were separated from full thickness 
sheets utilizing the procedure described by Kligman 
and Christophers (10). Freshly separated epidermal 
sheets were used in all the experiments.
In vitro permeation of RGE using excised rat 
epidermis
Freshly obtained epidermal sheets were mounted 
between the donor and receptor compartments of 
vertical Franz glass diffusion cells. The epidermal 
sheet was equilibrated for 4 hrs using phosphate 
buffer of pH 7.4 (PB) in receptor compartment. The 
equilibration was judged to be completed when the 
fluid  content  in  receptor  compartment  (phosphate 
buffer of pH 7.4) did not exhibit any fluorescence on 
being analyzed spectrofluorimetrically at excitation 
and emission spectra of 282 nm and 379 nm, 
respectively. The receptor compartment was filled 
with fresh PB (pH of 7.4) containing sodium azide 
(0.05% w/v) as preservative and PEG 400 (10% v/v) 
as solubilizing agent. The temperature of the receptor 
compartment was maintained at 35±2°C. The donor 
compartment was loaded with dispersion of RGE 
(2 mg) in PG: EtOH (7:3) mixture or dispersion of 
RGE (2 mg) and AA-E (1-6% w/v) in PG: EtOH 
(7:3)  mixture  and  sealed  with  parafilm.  Samples 
(1.0  ml)  from  the  receptor  fluid  were  withdrawn 
at different time intervals during 48 hrs and 
immediately analyzed spectrofluorimetrically using 
excitation and emission wavelengths of 282 nm and 
379 nm, respectively. Standard plot of RGE solution 
was prepared in PB containing sodium azide (0.05% 
w/v) and PEG 400 (10% v/v) spectrofluorimetrically 
using excitation and emission wavelengths of 282 
nm and 379 nm, respectively.
In vitro permeation of RGE across epidermis 
obtained after treatment of viable rat skin
One patch (7cm2) was prepared on dorsal side of 
rat by shaving with mechanical clipper. The patch 
was treated with selected dose of AA-E (5% w/v). 
Surface area exposed to treatment was kept constant. 
The animals were sacrificed after 4, 8, 12, 24, 36 
or 48 hrs. The treated skin patches were excised, 
epidermis separated and used for different in vitro 
permeation studies of RGE. All experiments were 
carried out in triplicate.  
Biochemical estimation of skin microconstituents  
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w/v) dispersed in PG: ETOH (7:3) mixture were 
prepared using adhesive tape, polyethylene backing 
membrane, and a rubber ring and applied to shaved 
skin of the dorsal portion of rats. The animals were 
sacrificed after 4, 8, 12, 24, 36 or 48 hrs and the 
epidermis was separated from treated skin patches. 
All epidermal sheets were dried to constant weight 
at 50ºC and total lipids were extracted by the 
Folch method (11). Cholesterol and triglycerides 
contents in these extracts were determined by using 
respective kits. Sphingosine content was determined 
spectroflourometrically (SL 174, Elico, India) using 
excitation and emission wavelengths of 340 and 455 
nm, respectively, according to the method outlined 
by Sharma et al. (12). All determinations were 
carried out in triplicate.
Transmission electron microscopic (TEM) studies 
Excised epidermal samples treated with AA-E (1-6% 
w/v) for 48 hrs or epidermis obtained from viable 
skin excised after similar treatments for different 
time intervals (4, 12, 24, 36 and 48 hrs) were fixed 
in  Karnovosky’s  fixative  [(2%  paraformaldehyde 
and 1% (w/v) glutaraldehyde in 0.1M phosphate 
buffer (pH of 7.4)] and processed. Ultra-thin (60-
90°A) sections were cut and double stained with 
uranyl acetate and lead citrate for TEM observation 
(Morgagni 268 D, Sei, Netherlands).
Scanning electron microscopic (SEM) studies
The methods used were similar to those reported 
earlier (13). Photographs were taken under scanning 
electron microscope (LEO 435 SVP, Cambridge, 
UK).
Cells, media and culture condition
Human normal skin keratinocyte cell line (HaCaT), 
provided by Professor Sudhir Krishna, (National 
Centre for Biological Sciences, Bangalore, India) 
was maintained in Dulbecco modified eagle medium 
(DMEM) (Sigma-Aldrich USA) containing 10% 
fetal bovine serum (FBS), 100 units/ml penicillin and 
100 µg/ml streptomycin (Invitrogen life sciences, 
USA). The FBS for culturing HaCaT cells was heat 
inactivated for 30 min at 55°C. HaCaT cells were 
cultivated according to the method described by 
Brandner et al. (4). The cells were incubated until 
they were approximately 50-60% confluent. Cells 
were made serum free at 16-24 hrs prior fixation 
and treated with solutions containing different 
concentrations of AA-E for 6 hrs. AA-E (50 mg) was 
dissolved in PG: EtOH (7:3) mixture. The solutions 
were sterilized by filteration (Sartolab. vl15, pore size 
0.2 lam) and serially diluted in Dulbecco modified 
eagle medium to obtain solutions of 0.0025, 0.005, 
0.01, 0.02, 0.04, 0.08, 0.16, 0.32, 0.8 or 1 µg/µl of 
AA-E. Confluent cells were treated with different 
concentrations of AA-E. Untreated cells served as 
control. The cells were cultured in the conditions 
described above for 6 hrs. The growth of cells was 
monitored under a light microscope. All experiments 
were repeated three times.
Immunoflourescence
Fixation was performed by immersing the cells 
into freshly prepared 4% v/v paraformaldehyde 
for 10 min. Immediately after fixation, cells were 
permeabilized with 0.1% v/v TritonX-100 (Sigma) 
for 5 min. Cells were then rinsed with phosphate 
buffer saline (PBS) for 3 min. and blocked in 10% 
FBS in PBS for one hour. This was followed by 
incubation with primary anti-TJP1 (ZO-1) antibody 
(1:100 dilution) for 2 hrs at room temperature (or 
overnight at 4°C). After rinsing of each of them three 
times in PBS for 10 min, cover slips were incubated 
with FITC-conjugated anti-rabbit IgG (10 µg/ml) 
in PBS containing 2% w/v FBS for 2 hrs. Slides 
were then rinsed three times in PBS and cover slips 
were mounted in antifade mounting medium (Vector 
laboratories, USA). Nucleus was stained using 
propidium iodide (5 µg/ml). Control for antibody 
specificity  was  prepared  by  omitting  the  primary 
antibody. The control demonstrated minimal or 
no staining. For microscopic examination, a Zeiss 
Axioplan fluorescence microscope (Zeiss) equipped 
with a confocal scanning unit MRC-600 (Bio-rad) 
and an argon-Krypton laser were used.
RNA Isolation and Semi-quantitative RT-PCR 
Total RNA was extracted from HaCaT cells after 
treatment with different concentrations of AA-E 
using TRI-reagent (Sigma-Aldrich, St. Louis, USA) 
according to the manufacturer’s protocol. Two 
micrograms of total RNA was reverse transcribed 
using high capacity cDNA archive kit (Applied 
Biosystems, USA). cDNA equivalent to 20 ng of 
total RNA was used for the PCR reactions. The PCR 
reactions were performed using 2X DyNAzymeTM 
Master Mix (FINNZYMES, Finland) with ZO-1 and 
occludin specific primers in a final reaction volume 
of 20µl. The primer sequence used for ZO-1 and 
occludin was 5’CTTCAAAGGGAAAGCCTC3’(f
orward)5’TACCTTCACCATGCTCC 3’(reverse),5
’CTGGATCAGGGAATATCCAC3’(forward)and5’
TCAGCAGCAGCCATGTAC 3’ (reverse). 
Evaluation of pharmacokinetic parameters of RGE 
in animals
Wistar albino rats of either sex (230-250g) were used 
for the bioavailability studies. The rats were housed 
under controlled environmental conditions (23±2°C; 
55±5% RH) and fed with a commercial diet with 
free access to water. About 10 cm2 of skin was 
shaved with electric razor on the dorsal side. Rats 
were observed for 24 hrs for any untoward effect 
of shaving.  The rats were divided into 4 groups 
(n=6). Group I received oral administration of RGE 
(0.5 mg) after overnight fasting. Group II received Angelica archengelica extract 4
transdermal patch A containing RGE and AA-E (1% 
w/v) dispersed in PG: EtOH (7:3) mixture, group III 
and IV received transdermal patch (B) containing 
RGE and AA-E (5% w/v) or (6% w/v) dispersed in 
PG:EtOH (7:3) mixture, respectively. Blood sample 
(0.3 ml) via the post-orbital venous plexus vein was 
collected in heparinized tubes at 1, 2, 4, 6, 8, 12, 
24, 28, 36, 42 and 48 hrs. The blood samples were 
transferred to heparinized eppendroff tubes mixed 
gently and centrifuged (4000 rpm, 5 min) to obtain 
200 µl plasma and stored at −20oC until analysis. 
The concentration of RGE in the plasma was 
determined by HPLC analysis. The plasma samples 
(1 ml) were extracted using the procedure reported 
by Ruzilawati et al. (14). 
Transepidermal water loss (TEWL) determination
Wistar rats of either sex (approximately 250 g) 
were anesthetized. Patches were prepared as 
reported in pharmacokinetic studies. The patch 
received treatment with selected dose of AA (5% 
w/v) dispersed in PG:ETOH (7:3) mixture for 
different studies. The laboratory temperature and 
humidity were maintained at 23±2°C; 55±5% RH, 
respectively. Surface area exposed to treatment was 
kept constant. TEWL was recorded on each site after 
removal of the patch at 4, 8, 12, 24, 36 or 48 hrs 
by using Tewameter TM 210 (Courage + Khazaka 
Electronic GmbH, Koln, Germany). Data was stored 
and analyzed by the TEWAMETERÒ computer 
software.
Draize Test
The study employed albino rabbits (1.2-2.5 kg) 
of either sex (n=5) for testing skin irritation. Two 
patches each of two square inch area were prepared 
by shaving the dorsal surface of one rabbit. Patch 
made from two layers of light gauze was dipped 
in solutions containing different concentrations of 
extracts prepared in PG:EtOH (7:3). The animals 
were immobilized in the special holder during the 
24 hrs patch exposure. Upon removal of the patches 
the animals were observed for any sign of erythema 
or oedema for a period of 72 hrs. The observations 
were repeated after 72 hrs. 
Statistical analysis
Studentized t test was employed for comparing the 
data between two groups. The level of significance 
was fixed at 0.05.
RESULTS AND DISCUSSION
Characterization of Coumarin present in AA-E
AA-E subjected to HPTLC analysis using toluene: 
ethylacetate (9:1) as mobile phase gave single 
band characteristic of bergapten at 322 nm with Rf 
value of 0.30 (8). The AA-E was found to contain 
5.234% w/w of bergapten. Fig 1 (a) depicts the 
characteristic bands exhibited by pure bergapten 
(A1) as well as those exhibited by AA-E (A2-A4). 
Fig 1(b) shows the spectrograph corresponding to 
these samples.
In vitro permeation of RGE across rat epidermis
Table 1 summarizes the flux of RGE across excised 
rat epidermis treated with different concentrations of 
AA-E (1-6% w/v). The permeation of RGE across 
excised epidermis in the presence of 1% w/v AA-E 
was 2.62 fold greater than that in the presence of 
donor vehicle (PG:EtOH, 7:3). The permeation 
increased to 4.35-fold and 7.01-fold in the presence 
of AA-E 3% w/v or 5% w/v respectively as compared 
to that in the presence of vehicle. The permeation 
was ~7-fold higher in the presence of AA-E 6% w/v 
concentration as compared to that of vehicle which 
is almost comparable to that in the presence of AA-E 
5% w/v. 
Previous studies have reported coumarins are 
rapidly and extensively absorbed across skin into the 
receptor fluid (15). This high topical bioavailability of 
coumarins to some extent has been attributed to their 
physicochemical properties. An optimal lipophilicity 
(log Po/w =1.2) enables it to be readily taken up into 
the lipid regions of the stratum corneum. At the same 
time, the sufficient (albeit low) aqueous solubility 
allows its partitioning from the stratum corneum 
into the relatively aqueous viable epidermis, dermis, 
and  receptor  fluid  (15).  During  the  initial  stages, 
absorption of coumarins across mouse skin into the 
receptor fluid was observed to be considerably fast 
Treatment Flux of RGE (µg/cm2/h)* Enhancement ratio
PG:EtOH (7:3) 12.470 ± 1.12 -
AA-E (1% w/v) 32.671 ± 0.97 #a 2.620
AA-E (3% w/v) 54.232 ± 1.23 #a 4.349
AA-E (5% w/v) 87.439 ± 0.94 #a 7.012
AA-E (6% w/v) 85.420 ± 1.19 #a 6.850
*Mean ± S.D of three experiments; # With respect to PG: EtOH (7:3); ‘a’ indicates significant difference (p < 0.05) with respect to 
PG:EtOH (7:3).
Enhamcement ratio is the ratio of flux of RGE across rat epidermis in the presence of respective concentration of ethanolic extract 
of Angelica archengelica (AA-E) dispersed in propylene glycol: ethanol mixture to that of  the control in 7:3 mixture of PG: EtOH.
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and more extensive, probably due to significant role 
of the hair follicles as suggested previously for other 
compounds (16). Further, greater flux of coumarin 
through excised cadaver scalp skin compared to 
that through abdominal skin has been reported. 
This was again attributed to the higher hair follicle 
density in the former (169/cm2) than in the latter 
(24/cm2) (17). Therefore, the ability of coumarins to 
enhance the permeation seems to be a combination 
of its physicochemical properties and the number of 
functional permeation pathway.
The  effect  of  coumarins  on  membrane  fluidity  is 
attributed to its easy partitioning in the membrane 
(due  to  its  apolar  nature)  and  the  configuration 
it assumes with neighboring molecules in the 
membrane, resulting in altered lipid dynamics. 
Modulation of membrane protein function by its 
lipid environment is a well known phenomenon 
(18). Coumarins contain benzopyrene ring due to 
which they affect the protein portion of the skin 
constituents. The reduction of high protein oedema 
has been detected 4 hrs after administration and the 
maximum effect was evident at 12 hrs (19). In view 
of these reports and observed enhancement of RGE 
permeation across excised rat epidermis, it seemed 
essential to investigate the influence of AA-E on skin 
micro constituents and ultrastructure for gaining an 
insight into the exact mechanism of percutaneous 
permeation enhancement.
Biochemical estimation
The quantity of cholesterol, triglyceride, or 
sphingosine extracted from excised epidermis 
increased in the presence of increasing 
concentration  of AA-E up to 5% w/v. Treatment 
with AA-E (6% w/v) for 48 hrs extracted the 
maximum amount of cholesterol (57.987%), 
followed by triglyceride (25.087%), and least 
amount of sphingosine 14.234% (Table 2). It is 
interesting to note that all these treatments were less 
effective when applied to viable skin as shown in 
table 2. Further, the maximum effect in viable skin 
was observed when epidermis was excised after 12 
hrs treatment with 5% w/v AA-E (Fig 2). Therefore, 
AA-E may be suggested to influence the permeation 
of RGE through modulation of epidermal barrier 
status by affecting the skin micro constituents.
Transepidermal water loss (TEWL) studies
The most important function of the skin is the control 
of the transepidermal water loss (TEWL). The 
TEWL of viable rat skin portions increased rapidly 
in the AA-E treated skin portion and was maximum 
(~ 6-fold) higher after 12 hrs as compared to the 
untreated portion (Fig 2). Further, the permeation 
of RGE across the skin portions excised after 
12  hrs  of  treatment  with AA-E  was  significantly 
(P<0.05)  higher  as  compared  to  that  across  skin 
portions excised at other time periods (Fig 2). 
The flux of RGE and TEWL at later time intervals 
decreased  continuously.  The  lack  of  significant 
difference  (P<0.05)  in  the  permeation  of  RGE 
across AA-E treated epidermal sheets excised after 
48 hr of treatment suggested normalization of skin 
microconstituents that would have accompanied the 
restoration of barrier properties of skin. It is evident 
from figure 2  that the TEWL of skin treated with 
AA (5% w/v) was only ~2-fold higher in the AA-E 
Formulation Skin microconstituent extracted (%) #
Cholesterol Triglyceride Sphingosine
Skin Type: Excised after 48 hrs of treatment
AA-E  (1%w/v) 22.934 ± 3.23 12.345 ± 1.96 7.121 ± 2.34
AA-E (3%w/v) 25.305 ± 0.99 14.087± 2.99 8.293 ± 3.26
AA-E (5%w/v) 57.987 ± 1.76 25.087 ± 0.66 14.234 ± 2.17
AA-E (6%w/v) 31.237 ± 2.09 17.456 ± 2.97 9.345 ± 1.07
Skin Type: Viable treated with AA-E  (5% w/v)
4hrs 17.118 ± 2.87 6.027 ± 0.99 3.093 ± 1.34
8hrs 21.235 ± 3.98 13.924 ± 2.07 6.125 ± 0.91
12 hrs 34.143 ± 4.02 27.176 ±1.35 23.012 ± 2.09
24 hrs 27.567 ± 1.29 16.623 ± 2.87 15.637 ± 2.56
36 hrs 24.109 ± 1.35 13.154 ± 1.97 11.734 ± 0.91
48 hrs 16.345 ± 1.75 5.034 ± 3.02 4.467 ± 2.09
# Mean ± S.D of three experiments
This table shows the percentage of extracted skin microconstituents across excised rat epidermis using Folch method by applying 
transdermal patches containing Angelica archengelica extract  (AA-E) (1-6% w/v)  and across viable rat epidermis using AA-E                 
(5% w/v) dispersed in PG: ETOH (7:3) mixture.
Table 2. Effect of treatment with Angelica archangelica extract (AA-E) on microconstituents of epidermis in excised and viable rat 
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treated skin portion after 48 hrs as compared to 
untreated skin portion. Hence, weaning off the effect 
of AA-E after 48 hrs of treatment could be attributed 
to the recovery of barrier status of skin as a natural 
response phenomenon in a bid to restore its original 
condition. 
Electron microscopic studies
SEM photomicrographs of rat skin treated with 
different concentrations of AA-E (1-6% w/v) revealed 
loosening of stratum corneum (SC) surface layers in 
comparison to control (Figs 3a-3f). Treatment with 
AA-E (5% w/v) resulted in formation of largest pores 
Figure 1. Bands charaterstic of bergapten (a) and corresponding retention time (b) obtained by HPTLC analysis of pure bergapten (A1) 
or replicate samples of AA-E (A2-A3).
a b
 
 
 
Figure 1. Bands charaterstic of bergapten (a) and corresponding retention time (b) obtained after 
HPTLC analysis of pure bergapten (A1) or replicate samples of AA-E (A2-A3). 
 
 
 
Figure 2.  Enhancement ratio (ER) of RGE and TEWL of viable rat epidermis after treatment 
with  AA-E (5% w/v) . The horizontal bars for each observation represent standard deviation of 
three experiments (n = 3). “a” indicates significant difference (p < 0.05) with respect to TEWL 
of control group. 
 
Figure 2. Enhancement ratio (ER) of RGE and TEWL of viable rat epidermis after treatment with  AA-E (5% w/v) . The horizontal bars 
for each observation represent standard deviation of three experiments (n=3). “a” indicates significant difference (p<0.05) with respect 
to TEWL of control group.
coupled with loosening of SC surface (Fig 3d). The 
effect was apparently of less intensity when AA-E 
(5% w/v) was applied to viable skin (Fig 3f). TEM 
micrographs of untreated rat epidermis revealed 
closely packed SC cell layers and tightly packed 
keratin pattern (Fig 4a). Greatest extent of lipid 
area disordering and increase in intercellular space 
along with corneocyte detachment was observed 
after treatment of excised skin with 5% w/v of AA-E 
(Fig 4d). These effects were apparently less severe 
when the viable skin was treated with 5% w/v of 
AA-E (Fig 4f). The less severe influence of these 
treatments on ultrastructural features of viable skin 
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Figure 3. Scanning electron photomicrographs of rat skin: untreated epidermis (a); excised skin treated for: 48 hrs with AA-E (1-6% w/v)   
(b-e); as well as viable skin treated for 12 hrs with 5% w/v AA-E (f).
[Broken arrows indicate loosening of SC surface and solid arrows indicate formation of surface pores, magnification is ×500, shorter scale 
bar is 10 μm, and longer scale bar is 20 μm
a b c
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Figure 4. Transmission electron photomicrographs of rat skin: untreated epidermis (a); excised skin treated for: 48 hrs with AA-E (1-6% 
w/v)  (b-e); as well as viable skin treated for 12 hrs  with 5% w/v AA-E (f).
[Broken arrows indicate disruption of lipid areas and solid arrows indicate corneocyte detachment, magnification is ×20,000, scale bar 
is 100 nm]Angelica archengelica extract 8
Figure 5. Confocal laser scanning photomicrographs of HaCaT cells: without treatment with antibodies (a); after treatment with primary 
anti-TJP1 (ZO-1) antibody labeled with FITC-conjugated anti rabbit IgG antibodies only (b); after treatment with 0.0025% w/v AA-E 
(c); 0.01% w/v AA-E (d); 0.02% w/v AA-E (e) ; 0.04% w/v AA-E (f); 0.08% w/v AA-E (g); 0.16% AA-E w/v (h), 0.8% w/v AA-E (i) 
and 1% w/v AA-E (j).
[Propidium iodide (PI) stained red colored nucleus (a); Fluorescence due to attachment of primary anti-TJP1 (ZO-1) antibody labeled with 
FITC-conjugated anti rabbit IgG antibody indicates presence of ZO-1 protein in cell boundaries (b-j). The solid arrows indicate presence 
of demarcating cell boundaries and broken arrows indicate disruption of demarcating cell boundaries, Scale mode plane, scale bar: 0.7µm]
could be ascribed to the continuous attempt of the 
skin to normalize its barrier status through enhanced 
lipid synthesis.
Confocal laser scanning microscopic (CLSM) 
studies
Confocal laser scanning microscopy was utilized to 
determine alterations in structural proteins.  Staining 
of the HaCaT cells with propidium iodide (PI) 
without treatment with antibodies resulted in red 
color staining of the nucleus (Fig 5a). Treatment 
with primary anti-TJP1 (ZO-1) antibody labeled 
with FITC-conjugated anti rabbit IgG was observed 
to exhibit continuous punctuate localization of 
ZO-1 along the cytoplasmic surface of the cell 
membrane,  staining  specifically  the  HaCaT  cell 
borders (Fig 5b). TJ-associated protein, ZO-1, was 
localized as a sharp, continuous band around the 
cell periphery in untreated cells. Treatment with 
different concentrations of AA-E for 6 hrs resulted 
in loss of ZO-1 from membrane regions indicating 
the loss of functional tight junctions from such Kaushal et al / DARU 2011 19 (1) 1-11 9
 
Figure 6. Pharmacokinetic profile of RGE after oral administration of tablets (0.5 mg) and 
transdermal patches (A: 1%w/v AA-E; B: 5%w/v AA-E; C: 6%w/v AA-E) formulations. The 
horizontal bars for each observation represent standard deviation of three experiments (n = 3). 
“a” indicates significant difference (p < 0.05) with respect to oral administration. 
 
Figure 7. Effect of AA-E on the expression of tight junction proteins in human keratinocyte  
Exponentially growing HaCaT cells were serum starved for 24 hrs and treated with different 
concentrations of AA-E for 12hrs. mRNA levels of ZO-1 and occludin upon AA-E treatment and 
relative mRNA expression from the densitometric data after normalization to RPL-35a [Data is 
representative of three independent experiments].  
Figure 6. Pharmacokinetic profile of RGE after oral administration of tablets (0.5 mg) and transdermal patches (A: 1%w/v AA-E; B: 
5%w/v AA-E; C: 6%w/v AA-E) formulations. The horizontal bars for each observation represent standard deviation of three experiments 
(n=3). “a” indicates significant difference (p<0.05) with respect to oral administration.
Time (hr)
areas indicative of diminished TJ integrity (Figs 
5c-j). Treatment of HaCaT cells with 0.0025% w/v 
of AA-E resulted in a decrease in the intensity of 
immunofluorescence  around  the  cell  boundaries 
(Fig 5c) as compared to the untreated cells (Fig 5b). 
Increasing the concentration of AA-E to 0.01% w/v 
further decreased the immunofluorescence of HaCaT 
cells (Fig 5d). The cells started separating from each 
other on treatment with 0.02% or 0.04% w/v AA-E 
(Fig 5e and 5f). At higher concentration of 0.08% 
w/v of AA-E (Fig 5g) HaCaT cells were observed 
as pentagonal shaped cells with rare cell-to-cell 
connection. The cell boundaries appeared highly 
diffused after treatment with 0.16% w/v AA-E (Fig 
5h).  The  immunofluorescence  was  significantly 
diffused along the cell borders as well as in the 
cytoplasmic region with no demarcation of cell–cell 
connection between adjacent cells when 0.8% w/v 
(Fig 5i) or 1% w/v (Fig 5j) concentrations of AA-E 
were employed.
Evaluation of pharmacokinetic parameters of RGE 
in animals
Transdermal patch (A) containing 1% w/v of AA-E 
yielded Cmax of 26.2 ng/ml as compared to17.96 ng/
ml observed after oral administration. The Cmax was 
further enhanced by ~2-fold (34.3 ng/ml) and ~2.5-
fold (42.3 ng/ml) as compared to oral administration 
after application of transdermal patch containing, 5% 
w/v or 6% w/v of AA-E respectively. However, the 
time taken to achieve Cmax was significantly delayed 
(P> 0.05) from one hour (oral administration) to 
12 hrs (transdermal administration). It is important 
to note that the minimum effective concentration 
reported for human after an oral dose of 2 mg of 
RGE is 27.74 ng/ml (20). This concentration was 
not achieved in rats in the present investigation 
after oral administration of tablets containing 0.5 
mg RGE. Further, the plasma RGE concentration 
declined sharply after one hour and was negligible 
after 2 hrs of oral administration of tablets. On the 
other hand, the plasma RGE concentration attributed 
to maintenance of minimum effective concentration 
of 27.7 ng/ml for 18.5 or 19.1 hrs after application 
of transdermal patch containing, 5% and 6% w/v 
of AA-E respectively. However, transdermal patch 
containing AA-E (1% w/v) was unable to maintain 
minimum effective concentration of 27.7 ng/ml. 
Effect of AA-E on ZO-1 and occludin expression in 
HaCaT cells
The densitometric data obtained indicated that 
the m-RNA levels related to both ZO-1 as well as 
occludin remained unaffected when the HaCaT cells 
were incubated with 0.02, 0.08, 0.16, 0.8 and 1% w/v 
concentrations of AA-E for 12 hrs (Fig 7). However, 
the gene expression for these tight junctional 
proteins decreased slightly by 1% w/v concentration 
of AA-E. Although, it is difficult to extrapolate these 
findings  to  the  exact  safe  concentration  range  of 
AA-E for use on rat skin, the data does suggest a 
wide concentration range of AA-E that seems safe 
for use on HaCaT cells and possibly on rat skin.
Draize Test:
The results of draize test did not suggest any irritation 
potential of AA-E on rabbit skin.
CONCLUSION
Result of the present investigation revealed that 
P
l
a
s
m
a
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
o
f
 
R
G
E
 
(
n
g
/
m
l
)Angelica archengelica extract 10
AA-E (5%   w/v) enhanced the permeation of 
RGE across excised rat epidermis by 7-fold. AA-E 
was found to perturb the lipid microconstituents 
in both excised and viable rat skin, although, 
the effect was less intense in the later. The 
perturbation was manifested in the higher TEWL 
values of the viable rat skin treated with AA-E 
(5% w/v). Further, intercellular loosening and 
pores were evident in SEM photomicrographs 
of AA-E treated rat epidermis. The TEM 
photomicrographs also revealed distorted lipid 
area along with increase in intercellular space and 
corneocytes detachment after similar treatment 
of rat epidermis. The CLSM investigations on 
HaCaT cells revealed loss of functional tight 
junction after treatment with AA-E 0.16% w/v 
for 6 hrs. Draize test revealed that AA-E did not 
irritate rabbit skin. The plasma concentration 
was maintained higher and for longer time by 
transdermal formulation as compared to oral 
administration  of  RGE.  Overall,  the  findings 
suggested  that  the  overwhelming  influence  of 
AA-E in enhancing the percutaneous permeation 
of RGE to be mediated by its influence on skin 
lipids and tight junction protein (ZO-1).
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Figure 7. Effect of AA-E on the expression of tight junction proteins in human keratinocyte 
Exponentially growing HaCaT cells were serum starved for 24 hrs and treated with different concentrations of AA-E for 12hrs. mRNA 
levels of ZO-1 and occludin upon AA-E treatment and relative mRNA expression from the densitometric data after normalization to RPL-
35a [Data is representative of three independent experiments].
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